13F HOLDINGS REPORT
RA CAPITAL MANAGEMENT, L.P.
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001104659-23-091405
Total Value
$5.30B
Positions
54
Other Managers
0
Confidential Omitted
No
Holdings (54)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ASCENDIS PHARMA A/S | ASND | 11,225,357 | $1.00B | 18.92% |
| 2 | LEGEND BIOTECH CORP | LEGN | 6,264,707 | $432.5M | 8.16% |
| 3 | VAXCYTE INC | PCVX | 7,891,254 | $394.1M | 7.44% |
| 4 | DICE THERAPEUTICS INC | 23345J104 | 7,856,612 | $365.0M | 6.89% |
| 5 | 89BIO INC | 282559103 | 11,416,948 | $216.4M | 4.08% |
| 6 | BIOGEN INC | BIIB | 532,892 | $151.8M | 2.87% |
| 7 | AEROVATE THERAPEUTICS INC | 008064107 | 8,263,982 | $141.7M | 2.68% |
| 8 | VERONA PHARMA PLC | 925050106 | 6,317,990 | $133.6M | 2.52% |
| 9 | CUREVAC N V | N2451R105 | 12,245,955 | $127.6M | 2.41% |
| 10 | TYRA BIOSCIENCES INC | TYRA | 7,236,454 | $123.2M | 2.33% |
| 11 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 9,000,000 | $107.0M | 2.02% |
| 12 | CYTEK BIOSCIENCES INC | CTKB | 12,297,721 | $105.0M | 1.98% |
| 13 | JANUX THERAPEUTICS INC | JANX | 8,670,644 | $102.9M | 1.94% |
| 14 | GERON CORP | GERN | 31,544,806 | $101.3M | 1.91% |
| 15 | INHIBRX INC | INBX | 3,853,867 | $100.0M | 1.89% |
| 16 | RHYTHM PHARMACEUTICALS INC | RYTM | 5,676,067 | $93.6M | 1.77% |
| 17 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 7,809,852 | $93.2M | 1.76% |
| 18 | RXSIGHT INC | RXST | 3,052,796 | $87.9M | 1.66% |
| 19 | COGENT COMMUNICATIONS HLDGS | COGT | 6,416,147 | $76.0M | 1.43% |
| 20 | PEPGEN INC | PEPG | 8,131,952 | $72.7M | 1.37% |
| 21 | AXSOME THERAPEUTICS INC | AXSM | 1,000,000 | $71.9M | 1.36% |
| 22 | AVIDITY BIOSCIENCES INC | 05370A108 | 6,416,998 | $71.2M | 1.34% |
| 23 | VOR BIOPHARMA INC | VOR | 22,748,880 | $70.3M | 1.33% |
| 24 | GH RESEARCH PLC | GHRS | 5,587,333 | $66.3M | 1.25% |
| 25 | WAVE LIFE SCIENCES LTD | WVE | 17,202,009 | $62.6M | 1.18% |
| 26 | ACRIVON THERAPEUTICS INC | ACRV | 4,810,508 | $62.3M | 1.18% |
| 27 | ICOSAVAX INC | 45114M109 | 5,963,565 | $59.2M | 1.12% |
| 28 | ITEOS THERAPEUTICS INC | 46565G104 | 4,417,259 | $58.5M | 1.10% |
| 29 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 3,069,531 | $55.5M | 1.05% |
| 30 | MINERALYS THERAPEUTICS INC | MLYS | 3,178,476 | $54.2M | 1.02% |
| 31 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 4,691,178 | $48.2M | 0.91% |
| 32 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,007,946 | $47.8M | 0.90% |
| 33 | ACUMEN PHARMACEUTICALS INC | ABOS | 9,770,773 | $47.0M | 0.89% |
| 34 | ACLARIS THERAPEUTICS INC | ACRS | 4,398,453 | $45.6M | 0.86% |
| 35 | IMMUNOGEN INC | 45253H101 | 2,329,958 | $44.0M | 0.83% |
| 36 | ENLIVEN THERAPEUTICS INC | ELVN | 2,122,465 | $43.3M | 0.82% |
| 37 | FULCRUM THERAPEUTICS INC | FULC | 11,609,704 | $38.3M | 0.72% |
| 38 | ELIEM THERAPEUTICS INC | CLYM | 13,150,849 | $36.8M | 0.70% |
| 39 | TENAYA THERAPEUTICS INC | TNYA | 6,067,483 | $35.6M | 0.67% |
| 40 | AN2 THERAPEUTICS INC | ANTX | 3,773,517 | $32.1M | 0.61% |
| 41 | PLIANT THERAPEUTICS INC | PLRX | 1,762,000 | $31.9M | 0.60% |
| 42 | EYEPOINT PHARMACEUTICALS INC | EYPT | 3,370,506 | $29.3M | 0.55% |
| 43 | ARS PHARMACEUTICALS INC | SPRY | 3,009,678 | $20.2M | 0.38% |
| 44 | WEREWOLF THERAPEUTICS INC | HOWL | 6,144,881 | $18.7M | 0.35% |
| 45 | DESIGN THERAPEUTICS INC | DSGN | 2,971,231 | $18.7M | 0.35% |
| 46 | SOLID BIOSCIENCES INC | SLDB | 3,426,286 | $18.0M | 0.34% |
| 47 | BLACK DIAMOND THERAPEUTICS I | BDTX | 3,525,754 | $17.8M | 0.34% |
| 48 | NKARTA INC | NKTX | 7,805,129 | $17.1M | 0.32% |
| 49 | CELCUITY INC | CELC | 1,400,001 | $15.4M | 0.29% |
| 50 | IGM BIOSCIENCES INC | 449585108 | 937,500 | $8.7M | 0.16% |
| 51 | CONNECT BIOPHARMA HLDGS LTD | CNTB | 6,991,003 | $7.9M | 0.15% |
| 52 | TALARIS THERAPEUTICS INC | 87410C104 | 2,333,175 | $7.1M | 0.13% |
| 53 | NANOSTRING TECHNOLOGIES | 63009R109 | 1,723,373 | $7.0M | 0.13% |
| 54 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 333,333 | $696,666 | 0.01% |